SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Smoking, nicotine and pregnancy 2 (SNAP2) trial: protocol for a randomised controlled trial of an intervention to improve adherence to nicotine replacement therapy in pregnancy

Clark, M; Cooper, S; Naughton, F; Ussher, MH; Emery, J; McDaid, L; Thomson, R; Phillips, L; Bauld, L; Aveyard, P; et al. Clark, M; Cooper, S; Naughton, F; Ussher, MH; Emery, J; McDaid, L; Thomson, R; Phillips, L; Bauld, L; Aveyard, P; Torgerson, D; Berlin, I; Lewis, S; Parrott, S; Hewitt, C; Welch, C; Parkinson, G; Dickinson, A; Sutton, S; Brimicombe, J; Bowker, K; McEwen, A; Vedhara, K; Coleman, T (2024) Smoking, nicotine and pregnancy 2 (SNAP2) trial: protocol for a randomised controlled trial of an intervention to improve adherence to nicotine replacement therapy in pregnancy. BMJ Open. ISSN 2044-6055 (In Press)
SGUL Authors: Ussher, Michael Henry

[img] Microsoft Word (.docx) Accepted Version
Restricted to Repository staff only until 30 May 2025.

Download (186kB)

Abstract

Introduction: Smoking in pregnancy is harmful for unborn babies, infants, and women. Nicotine replacement therapy (NRT) is offered as usual stop smoking support in the UK. However, this is often used in insufficient doses, intermittently, or for too short a time to be effective. This randomised controlled trial (RCT) explores whether a bespoke intervention, delivered in pregnancy, improves adherence to NRT and is effective and cost effective for promoting smoking cessation. Methods and analysis: A two-arm parallel-group RCT for pregnant women aged ≥ 16 years and who smoke ≥1 daily cigarette (pre-pregnancy smoked ≥5), and who agree to use NRT in a quit attempt. Recruitment is from antenatal care settings and via social media adverts. Participants are randomised using blocked randomisation with varying block sizes, stratified by gestational age (<14 weeks or ≥14 weeks) to receive: i) usual care stop smoking support (UC) or ii) UC plus an intervention to increase adherence to NRT, called “Baby, Me and NRT”, comprising adherence counselling, automated tailored text messages, a leaflet and website. The primary outcome is biochemically validated smoking abstinence at or around childbirth, measured from 36 weeks gestation. Secondary outcomes include NRT adherence; other smoking measures; and birth outcomes. Questionnaires collect follow up data which are augmented by medical records information. We anticipate quit rates of 10% and 16% in control and intervention groups respectively (RR = 1.6). By recruiting 1320 participants the trial should have 90% power (alpha = 5%) to detect this intervention effect. An economic analysis will use the Economics of Smoking in Pregnancy (ESIP) model to determine cost-effectiveness. Ethics and dissemination: Ethics approval was granted by Bloomsbury NHS Research Ethics Committee (21/LO/0123). Written informed consent will be obtained from all participants. Findings will be disseminated to the public, funders, relevant practice / policy representatives, researchers, and participants. Trial registration: ISRCTN16830506 Protocol version 5.0, 10 Oct 2023

Item Type: Article
Keywords: 1103 Clinical Sciences, 1117 Public Health and Health Services, 1199 Other Medical and Health Sciences
SGUL Research Institute / Research Centre: Academic Structure > Population Health Research Institute (INPH)
Journal or Publication Title: BMJ Open
ISSN: 2044-6055
Dates:
DateEvent
24 April 2024Accepted
Projects:
Project IDFunderFunder ID
RP-PG-0615-20003National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
URI: https://openaccess.sgul.ac.uk/id/eprint/116453

Actions (login required)

Edit Item Edit Item